Contexte mondial de développement de la recherche en pharmacogénomique et justice en santé mondiale

Patrick Gladding, Harvey White, Jamie Voss, John Ormiston, Jim Stewart, Peter Ruygrok, Badi Bvaldivia, Ruth Baak, Catherine White, Mark Webster, Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study. Jacc-cardiovascular Interventions. ,vol. 2, pp. 1095- 1101 ,(2009) , 10.1016/J.JCIN.2009.08.018

R Dinwiddie, O Crawford, Recent advances in cystic fibrosis research. Journal of the Royal Society of Medicine. ,vol. 86, pp. 7- 10 ,(1993)

Bryn Williams-Jones, Oonagh P Corrigan, Rhetoric and Hype Where's the 'Ethics' in Pharmacogenomics? American Journal of Pharmacogenomics. ,vol. 3, pp. 375- 383 ,(2003) , 10.2165/00129785-200303060-00004

James O'Reilly, Amy Dalal, Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs. Annals of health law / Loyola University Chicago, School of Law, Institute for Health Law. ,vol. 12, pp. 295- ,(2003)

Lincoln C. Chen, Tim G. Evans, Richard A. Cash, Health as a Global Public Good Global Public Goods. pp. 284- 305 ,(1999) , 10.1093/0195130529.003.0014

Amalio Telenti, Philip E Tarr, Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications. Antiviral Therapy. ,vol. 12, pp. 999- 1013 ,(2007)

3. The Imperative to Reduce Suffering: Charity, Progress, and Emergencies in the Field of Humanitarian Action Cornell University Press. pp. 73- 97 ,(2008) , 10.7591/9780801461538-005

Catherine Olivier, Le financement de la haute technologie dans le système de santé : le cas de la pharmacogénomique Les ateliers de l'éthique / The Ethics Forum. ,vol. 2, pp. 15- 26 ,(2018) , 10.7202/1044646AR

Lee K, Haines A, Walt G, The challenge to improve global health. JAMA. ,vol. 291, ,(2004)

Ronald Dworkin, What is Equality? Part 1: Equality of Welfare Philosophy & Public Affairs. ,vol. 10, pp. 81- 142 ,(2018) , 10.4324/9781315199795-6